New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.
A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose.
Suffolk sees a 251% increase in the number of ketamine users since 2022.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results